Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Analyst
Kevin McCarthy
Period: Reporting periods mapped to calendar 2024 Q3 – 2026 Q2 (8 quarters).
- Questions
- 69on tracked calls
- Challenge rate
- 4%3 of 69 questions
- Companies
- 10questioned at least once
- Reporting periods
- 8with questions
These figures cover the whole profile: every tracked question, all reporting periods.
How to read these numbers
Challenge rate is the share of questions that pushed back, pressed for specifics or questioned management’s assumptions. It describes how questions were asked on the calls tracked here; it does not measure whether any view turned out to be right.
Rounding. Rates are rounded to whole percentages, so a small share can show as 0% even when some questions were challenging. The count beside each rate is exact; “none of N questions” means no question was challenging.
No questions recorded. “—” means there is nothing to calculate: no questions were recorded for that period on the calls tracked here. It does not mean there was no activity.
Fewer than 3 questions. A company-level rate is withheld when fewer than 3 questions were recorded for that company; the questions are still counted everywhere else.
Small samples. Profiles with fewer than 10 questions are marked Limited sample.
Reporting periods. Questions are grouped by the calendar quarter each company’s fiscal reporting period maps to, not by the date of the call. Periods without a calendar mapping are listed separately under their fiscal label.
Questions asked
Grouped by company, most questions first. Open a company to read its questions, newest reporting period first.
Showing 69 of 69 questions from 10 companies
APDAir Products12 questions · 8 reporting periods · 0 of 12 challenging
Calendar 2026 Q2
conceptually, should investors think of that deal as fully hedging
Show response
Eduardo framed the Yara agreement as eliminating volume/offtake risk while APD retains most of the price risk, with a commission structure that shares upside as Yara commercializes the green ammonia.
Can you elaborate on the source of incremental goodness in the earnings function in helium?
Show response
Eduardo attributed helium improvement to new long-term agreements tied to electronics projects (mostly Asia, some U.S.) and supply reliability from the Texas cavern; Qatar volumes remain very limited so APD isn't counting on Middle East supply.
Calendar 2026 Q1
Can you speak to what you're baking into your financial guidance for volume growth in the back half of the year?
Show response
Eduardo explained guidance raise reflects Q2 beat only, with second half assumptions unchanged due to significant uncertainty from Middle East conflict.
Can you speak to your degrees of freedom on the supply side of the helium market? I appreciate you have large inventory buffer
Show response
Eduardo described Kansas liquefaction capacity and Texas cavern as key flexibility. Can cover one source down but not more. 900-mile supply chain from East Texas to Kansas.
Calendar 2025 Q4
can you comment on the sequential price change for helium and whether or not your Asia price of negative 1 would have been flat or possibly positive
Show response
Melissa confirmed Asia price would have been slightly positive ex-helium. Global helium price impact was -1%. Americas and Europe non-helium price was up more significantly.
can you comment on the expected timing of that event and the specific trigger
Show response
Melissa confirmed deconsolidation upon JV operations mid-2027. Debt comes off full balance sheet into equity affiliate line. Operating costs will ramp up pre-onstream then reduce to 33% share post-deconsolidation.
Calendar 2025 Q3
Would you comment on the market for rare gases, like crypton, xenon, neon, are you seeing any escalation of competitive intensity in Asia?
Show response
Eduardo acknowledged some pricing degradation and increased competition in rare gases but noted APD is not a significant player in this market.
Can you elaborate on the decision to sell to coal gasification projects in Asia curious about what exactly you're divesting
Show response
Eduardo confirmed Lu'An performing well and retained. Two other gasification projects with customer payment issues set aside for sale. Impact on sales limited as only paid sales were being booked. Seeking better owner for assets.
Calendar 2025 Q2
when do you think we might turn the corner? And how might you rank order the most important drivers to get those returns higher
Show response
Melissa explained ROCE is depressed by construction-in-progress (NEOM consolidation). Ex-CIP and cash, ROCE would be 500bp higher. Decline as project backlog completes will improve metric.
Calendar 2025 Q1
I think Air Products is pursuing partnerships for sequestration and also, as I understood, financial partners with an eye toward project financing. So how are those discussions going?
Show response
Eduardo emphasized capital cost certainty as the gating factor, not permits. Gave end-of-year timeline for partnership decisions.
Calendar 2024 Q4
I think Air Products has signaled in the past that you would intend to be free-cash flow positive in fiscal 2027, I believe. Is that still the case?
Show response
Melissa confirmed FY2027 net cash flow positive target, noting potential for equity partnerships or project financing to further improve trajectory.
Calendar 2024 Q3
would it be contingent upon bringing in a partner and/or project financing in Louisiana, or could you get there on an organic basis
Show response
Melissa confirmed 2027 net cash flow positive target assumes NO project financing or equity partnerships, purely from project on-stream timing.
CTVACorteva7 questions · 7 reporting periods · 0 of 7 challenging
Calendar 2026 Q2
In crop protection, organic sales were down about 6%. But, on a product line basis, it looks like the trend was lower
Show response
Chuck Magro framed a recovering market with volume growth and low single digit pricing down, but did not break out the product-line detail requested.
Calendar 2026 Q1
you might walk us through some of the next mileposts that you are most focused on in terms of the pending separation
Show response
Chuck outlined remaining milestones: HQ decisions in Q2, public Form 10 filing in Q2, board announcements in H2, capital structure finalization, and September 15 Investor Day.
Calendar 2025 Q4
do you expect that to happen in 2026? And what might it mean for Corteva over the medium to long term?
Show response
Chuck said EU framework agreed in December, expecting formal adoption by H1 2026. Still need China approval as last significant import market. Gene-edited fungal disease-resistant corn (disease super locus) looks fantastic in test fields, commercialization within 1-2 years of regulatory approval.
Calendar 2025 Q3
can you discuss how credit market conditions are evolving for growers in Latin America and what that means for Corteva
Show response
David acknowledged industry seeing higher borrowing costs and increased bankruptcies. Corteva managing well, past dues as % of AR improved 200bp YoY. About 40% of Brazil sales on barter system for risk mitigation.
Calendar 2025 Q2
I want to dive into fungicides, which was up 40%
Show response
Robert said fungicide growth driven by Onmira brand return to Brazil market at acceptable margins after 2023 price declines. FMC Forcivo partnership gives premium 3-way corn fungicide for North America.
Calendar 2025 Q1
talk a little bit about the ramp to the economic opportunity. Are you still on track for a 2027 launch in hybrid red winter wheat?
Show response
Chuck confirmed on track for 2027 hybrid wheat launch with 10-20% yield unlock, $1B peak revenue potential. Winter canola pilot expanding from 30,000 to potentially hundreds of thousands of acres.
Calendar 2024 Q4
crop protection EBITDA margins increased 800 basis points year over year
Show response
Robert attributed margin gains to biologicals, new products, spinosyns, favorable mix toward fungicides/insecticides, and $170M cost takeout in Q4.
DOWDow Inc.7 questions · 7 reporting periods · 0 of 7 challenging
Calendar 2026 Q2
Can you talk about what you're baking into your guide for U.S. Gulf Coast operations in the third quarter
Show response
Carter guided operating rates above 90% once the cracker turnaround completes and said the Thailand JV has adequate feedstock with improved margins.
Calendar 2026 Q1
Would love your thoughts on that subject in terms of physical damage to assets in the Middle East, new plants that we thought might be starting up that are in fact unable to do so
Show response
Fitterling said most attacks relatively limited and repairable within 275-day logistics window. Exception is Qatar LNG plant critical equipment requiring 2.5-3 years to rebuild. Partners actively working on repairs. Does not expect damage to extend beyond logistics constraint duration.
Calendar 2025 Q4
Can you talk about the variances that manifested in that segment versus your prior expectations?
Show response
Carter attributed weakness to building/construction and durables pressure globally. Fitterling said polyurethanes review active: took out 20% NA PO capacity; China 13% duty drawback expiring April; antidumping cases gaining traction.
Calendar 2025 Q3
How are your October and November order book shaping up relative to normal seasonal patterns?
Show response
Fitterling said order books right down the middle, not too conservative or optimistic. Cited Harvard report: US GDP ex data centers at 0.1%. MDI diverted from US showing up in Europe being dumped.
Calendar 2025 Q2
do you think $700 million could be a durable trough for quarterly earnings
Show response
Fitterling confirmed peak timing flexing toward 2030, declined to call trough. Focus on investing at bottom of cycle to maximize upcycle. Noted China starting to acknowledge overcapacity.
Calendar 2025 Q1
can you elaborate on how and why, I guess, you've expanded your scope of strategic review there with emphasis on polyurethanes
Show response
Fitterling said polyurethanes had a better owner. European ethylene capacity headed toward 20% reduction which should rebalance. Idle vs shutdown depends on optionality value, cited Saint Charles cracker story.
Calendar 2024 Q4
I was wondering if you'd walk-through your view of non-operating sources of cash-flow and uses in 2025
Show response
Fitterling provided comprehensive cash flow framework: ~70% conversion, CapEx $3-3.2B, dividend $2B, infrastructure $2.4-3B, net interest $600M. Nova progress expected during year.
LINLinde plc7 questions · 6 reporting periods · 0 of 7 challenging
Calendar 2026 Q2
if I look at your volume trend in Asia, it was up 6 percent for a second consecutive quarter.
Show response
Sanjiv attributed the 6% Asia volume to three parts: positive base volume, sizeable electronics sale-of-equipment, and ASEAN project ramp-ups.
Calendar 2026 Q1
If I look at your Americas number of plus 2%, I think that's the best that you've posted since the third quarter of 2022
Show response
White said not yet a true global recovery, need all 3 regions running positively. Americas results and trends are positive. Global base volumes turned positive but not enough to round to 1%. Need to see EMEA catalyst.
how much incremental volume opportunity do you think may be available again, through long-term contracts that you're pursuing
Show response
White confirmed excess molecules available beyond current commitments but declined to quantify. Being selective on contract quality and customer commitment. Already signed a few new long-term deals.
Calendar 2025 Q4
would you comment on your U.S. Packaged gas business sales trends with regard to both gas and rent and hard goods
Show response
Sanjiv detailed three indicators: hard goods automation equipment up (investment for expected pickup), consumables flat to slightly down, gas similar. Automotive and large ag equipment customers remain cautious with hope for H2 improvement. Cautious optimism but no consumption pickup yet.
Calendar 2025 Q3
you commented in the prepared remarks with regard to electronics, that you expect robust growth for some time
Show response
Sanjiv expects 9-11% semiconductor industry growth over 5 years to $1T. Logic steady, HBM/memory seeing significant pickup. Gas intensity continues increasing with advanced nodes. R&D engagement with OEMs confirms next-gen tools require even more gas.
Calendar 2025 Q2
what impact, if any, does the passage of the One Big Beautiful Bill Act have maybe internally for Linde?
Show response
Matt said minimal ETR impact but positive for cash taxes via reinstated bonus depreciation. IRRs on US projects could improve ~100bp. Enhanced 45Q supports blue hydrogen projects.
Calendar 2025 Q1
I'd be very interested to hear your updated thoughts on the near term, what you're seeing and hearing from your customers in April and May across end markets
Show response
Sanjiv gave detailed China view: steel weak, chemicals softer, but battery/EV and electronics growing. Medium-term growth moderated to low single digit IP. Smart plant AI reducing manning.
PPGPPG Industries7 questions · 7 reporting periods · 2 of 7 challenging
Calendar 2026 Q2
So maybe you can kind of unpack the volume growth trajectory as you see it in that business?
Show response
Direct answer quantifying about $25 million of new business wins per quarter and explaining the packaging comp math.
Calendar 2026 Q1
I think you made a small acquisition recently in [ Ozark ] as part of [ Traffic Solutions ]. Curious about that deal
Show response
Knavish described Ozark as opportunistic, highly synergistic bolt-on at about $100M revenue, purchased at good price relative to prior sale. Raises traffic solutions margin profile. Traffic solutions valued as stable cash generator funding aerospace investments. Broader M&A: PPG has always had balance sheet capacity; discipline continues. Must be right asset (adds organic growth/margin), right time, right price. Two small bolt-ons this year plus an Allied Products productivity acquisition. M&A still not tip of the spear.
Calendar 2025 Q4
If I look at the EBITDA line, though, it was relatively flat. And so I was wondering if you could walk us through your thoughts on operating leverage
Show response
Knavish attributed weak leverage to refinish destocking (double-digit Q3, high-single Q4 declines). Higher-margin business declining overwhelms other gains. Expects flip in H2 2026 when distributor buying patterns normalize. Morales clarified segment earnings actually grew ~$20M YoY in Q4.
Calendar 2025 Q3
your sales actually grew year-over-year, notwithstanding the refinish pressure that you articulated. And yet the operating income declined on a year-over-year basis
Show response
Knavish attributed OI decline to two factors: refinish mix (above-segment-average margins going negative) and above-normal growth spending in aerospace and PMC. Confident short-term margin hit delivers long-term shareholder value.
Calendar 2025 Q2
I think share gains are a meaningful part of that. So I was wondering if you could talk through the Performance segment and maybe help us conceptualize the gains
Show response
Knavish broke down $100M: most is auto OEM, then industrial coatings, then packaging. Packaging had known U.S. share loss offset by Europe gains and BPA NI technology wins. PMC driven by new technologies (SigmaGlide, Sale Advance, fire protection). Morales noted all 4 Performance businesses outgrew markets in Q2.
Calendar 2025 Q1
I was wondering if you could unpack the sales guidance that you've provided on Slide 11 for global architectural coatings in particular
Show response
Knavish declined to predict FX but confirmed incrementally positive pricing expected. Mexico project pause likely continues into Q2. Europe is the key change driver Q1 to Q2, momentum growing, could be flat to incrementally positive.
Calendar 2024 Q4
how do you expect volume to trend through the balance of the year? And how much of the implied improvement in the progression relates to potential macro uplift
Show response
Knavish outlined negative Q1 volumes ramping to positive low-single-digits for full year. Emphasized stabilization rather than hockey-stick recovery, with $100M industrial share gains providing visibility.
SHWThe Sherwin-Williams Company7 questions · 7 reporting periods · 0 of 7 challenging
Calendar 2026 Q2
are there certain businesses where you have been pleasantly surprised by the magnitude of share gains
Show response
Petz named commercial as the standout and new residential plus industrial wood as the hardest, restating the 1.5x to 2x market growth expectation.
Calendar 2026 Q1
have you implemented incremental pricing since the onset of the war on March 1
Show response
Ben clarified consolidated pricing includes both January stores increase and new incremental actions especially in Performance Coatings Group. On raws, expects heavier inflation in second half with exit rate at high end of low to mid single digits.
Calendar 2025 Q4
regarding the 7% price increase that you'd expect realization to be in the low single-digit percentage range.
Show response
Heidi said realization would be at the low end of the historic range as a full-year guide given the unique competitive environment.
Calendar 2025 Q3
Do you have any price increases on the table that you care to call out for consumer brands or across the Performance Coatings Group.
Show response
Al confirmed targeted price increases across Consumer Brands and Performance Coatings segments and regions to offset cost basket pressures.
Calendar 2025 Q2
you doubled the size of your previously announced restructuring program. Wondering if you could elaborate on the magnitude and flow through and sources of the savings
Show response
Al said 20% of $105M restructuring is in gross profit (plant consolidations), majority is SG&A; expects ~$80M annual savings with good portion in H2 and rest annualizing into 2026.
Calendar 2025 Q1
one of the things that changed relative to last quarter is you announced in February an agreement to acquire BASF's architectural business in Brazil. In that context, I was wondering if you could t...
Show response
Heidi said Suvinil is an obvious complement to existing LatAm business; targeting H2 close; not yet in guidance. Jim added Brazil architectural grows faster than GDP and Suvinil faster still.
Calendar 2024 Q4
you mentioned in your prepared remarks you're pursuing increases in consumer and performance coatings
Show response
Heidi said Consumer and PCG pricing is targeted by region/geography without announcing specifics. Al sized FX drag as ~1% consolidated, mid-teens hit in Latin America translating to mid-single-digit Consumer impact and ~2% PCG impact.
Show 4 more companies
ALBAlbemarle Corporation6 questions · 4 reporting periods · 0 of 6 challenging
Calendar 2026 Q2
Can you provide an update on where your own inventories are on a unit basis
Show response
Neal said inventories ended historically low (working capital 19% of sales versus a normal 25%) after strong demand and the CGP3 fire, and will need rebuilding.
Calendar 2026 Q1
does Albemarle have any visibility at all into whether your lithium molecules end up in an EV versus an energy storage system?
Show response
Masters said visibility is good but not perfect since the same customers serve both markets. Understanding end-market destination matters for planning capacities and market approaches. Norris added carbonate for LFP could go either way but on-the-ground knowledge helps discern.
I was wondering if you could speak to the quarterly cadence of your lithium sales volumes
Show response
Sheorey said Q1 is seasonally softest, Q2 and Q3 pick up, Q4 will not match prior year's strength due to inventory reductions in Q4 2025. Year-over-year comps get tougher through the year.
Calendar 2025 Q4
I would welcome your latest thoughts on potential to acquire lithium capacity versus build it
Show response
Masters said the focus is not on acquisitions at this point in the cycle. Organic growth opportunities at existing resources (La Negra, Chinese conversion facilities, tolling) are lower capital than greenfield. Would consider acquisitions at the right fit and price but not the current priority.
Calendar 2024 Q4
Can you comment on your outlook for 2025 in that end market? And is your share in grid storage higher or lower or about the same
Show response
Masters highlighted grid storage as a bright spot with continued growth expectations. Norris noted market share mirrors their LFP EV share since the same customers are involved.
as the tariff regimes continue to evolve here. Are you managing the company any differently today than you were last year
Show response
Masters said direct tariff impact is minimal since Albemarle does not ship significantly from China to the U.S., but watching knock-on effects on customers.
ECLEcolab6 questions · 6 reporting periods · 0 of 6 challenging
Calendar 2026 Q2
Is there a way to characterize or quantify the visibility that CoolIT has or you now have into the order backlog
Show response
Beck gave visibility only through the end of 2026 and described a go-to-market split between chip designers and hyperscalers, deferring backlog metrics to the November session.
Calendar 2026 Q1
It looks like you were able to decrease your ratio of SG&A to sales by 130 basis points in the March quarter
Show response
Kirkland noted 20-30bps of the 130bps improvement was Ovivo geography between GM and SG&A. Underlying still above 25-50bps long-term target. Full year SG&A leverage expected around 100bps.
Calendar 2025 Q4
Is that to do with the aforementioned normalization or stabilization in basic industries? Or are you expecting your higher growth platforms to accelerate as well?
Show response
Beck confirmed acceleration driven by both normalization of Paper/Basic Industries and continued momentum in growth engines growing double-digit. GHT growing strong double-digit with specific numbers to be published in Q1. Cooling-as-a-service getting great customer reception.
Calendar 2025 Q2
is it purely cyclical? Or do you see any structural elements that may argue for pulling some levers?
Show response
Beck confirmed no structural issues in basic industries. Power business has big future from AI/data center energy demand. Paper shifting from graphics to consumer products and specialized packaging. Neither business is a candidate for strategic exits.
Calendar 2025 Q1
I'm curious Christophe as to whether or not your thoughts on capital deployment have changed at all, with the external environment being so volatile
Show response
Beck confirmed no change to capital allocation. Net leverage 1.8x below 2x target. $140M share repurchases in Q1. M&A pipeline robust. Playing offense.
Calendar 2024 Q4
The relative margin differential between your US businesses and your international businesses and whether that's stable or narrowing or widening
Show response
Beck noted US above company average, international below but narrowing. All 11 global markets targeting 20% OI. FX drag 3%/4% is geographic mix.
LYBLyondellBasell6 questions · 6 reporting periods · 0 of 6 challenging
Calendar 2026 Q2
Welcome any comments that you have on other pieces of the portfolio, whether it's the propylene chain
Show response
Foley cited Middle East LPG-to-Asia flows, with North and Southeast Asia ex-China running about 50%, partly offset by U.S. LPG exports narrowing the gap.
Calendar 2026 Q1
that business earned quarterly EBITDA between $1.5 billion and $1.6 billion at the last peak in the middle quarters of 2021
Show response
Peter noted PE pricing only $0.10-$0.15/lb below 2021 peak with further price increases expected. Margins also improving as ethane costs are lower than end of 2025. Kim confirmed CMA forecast agrees mid-cycle PE margins will be reached in Q2, similar to 2021 conditions. Noted PP upside is different, $0.60 higher price in 2021 means PP may not run up as fast but spreads will continue increasing.
Calendar 2025 Q4
I'd appreciate your updated thoughts on the U.S. Gulf Coast market for polyethylene
Show response
Kim walked through multiple supporting factors: ACC data shows industry inventories fell from 44 days post-liberation to ~40 in November, likely lower in December. Higher Q4 ethane/nat gas hurt Q4 profitability. Winter Storm Fern took derivative capacity offline. Export pricing rising in January. Downstream converters announcing price increases. Peter confirmed multiple indicators supporting announced price increases with integrated margins expected to improve.
Calendar 2025 Q2
can you talk through the third quarter dynamics that you see in the Intermediates and Derivatives segment
Show response
Aaron explained Q1-to-Q2 step-up included one-time PO 11 JV exit costs in Q1. No material Q3 improvement expected across I&D. PO/derivative customers quoting 10%+ YoY declines. La Porte acetyls turnaround starts mid-September spanning Q3/Q4. Channelview methanol unit returning from unplanned outage will partially offset. Oxyfuels oversupplied in USGC with additional PO/TBA volume and Chinese exports displacing USGC.
Calendar 2025 Q1
I'm curious as to whether your forecast of things like demand growth and price premium levels have evolved at all
Show response
Peter confirmed circular volumes grew double-digit in Q1. Historically 57% per year growth over 3 years. Brand owners reduced aspirations due to supply constraints, not demand loss. MoReTec-2 FID expected in 2026, seeking brand owner commitments first.
Calendar 2024 Q4
I'd appreciate your updated cycle view on the propylene chain or polypropylene
Show response
Kim explained shift to lighter feedstocks reducing propylene supply, PDH units in China setting the floor. LYB investing in Flex 2 metathesis unit to secure propylene. Peter added NATPET JV expansion for low-cost PP and European capacity actions.
IFFInternational Flavors & Fragrances4 questions · 4 reporting periods · 1 of 4 challenging
Calendar 2026 Q2
I was wondering if you could elaborate on what impact the separation will have on your CapEx.
Show response
DeVeau said Remainco CapEx should run about 5% to 6% of sales (near the upper end near-term for high-return initiatives), with gross margin around 43%, EBITDA in the low 20s and SG&A 17-18%, improving as stranded costs come out.
Calendar 2025 Q4
finished on a somewhat stronger note. Can you elaborate on what drove the margin uplift there of 160 basis points year over year as the
Show response
Erik attributed H&B Q4 strength to volume growth and productivity. Health business showed less decline than Q3, expected to flatten in H1 2026 and return to growth in H2 2026 with full recovery in 2027.
Calendar 2025 Q2
you delivered some earnings upside in the first half, yet left the annual range is unchanged and now expect some growth to maybe moderate in the back half. So just wondering if you could parse that...
Show response
Erik pushed back on conservatism, citing two real challenges: health segment weakness (market plus internal commercial gaps) and fragrance ingredients commodity decline. Both expected to drag below market in H2 before recovering in 2026-2027.
Calendar 2025 Q1
Can you just elaborate on strategic rationale there, long-term opportunity, structure of the venture and timing of that cash investment
Show response
Erik detailed the 50/50 JV: EUR130M plant in Finland, split 50/50, startup by end of 2027. Kemira targets water treatment and packaging; IFF targets industrial applications.
Challenge rate by company
Every company this analyst questioned, most questions first. A company-level rate is shown from 3 questions; below that it is withheld.
| Company | Questions | Challenge rate |
|---|---|---|
| APD Air Products | 12 | 0%none of 12 questions |
| CTVA Corteva | 7 | 0%none of 7 questions |
| DOW Dow Inc. | 7 | 0%none of 7 questions |
| LIN Linde plc | 7 | 0%none of 7 questions |
| PPG PPG Industries | 7 | 29%2 of 7 questions |
| SHW The Sherwin-Williams Company | 7 | 0%none of 7 questions |
| ALB Albemarle Corporation | 6 | 0%none of 6 questions |
| ECL Ecolab | 6 | 0%none of 6 questions |
| LYB LyondellBasell | 6 | 0%none of 6 questions |
| IFF International Flavors & Fragrances | 4 | 25%1 of 4 questions |
- APDAir Products · 12 questions0%none of 12 questions
- CTVACorteva · 7 questions0%none of 7 questions
- DOWDow Inc. · 7 questions0%none of 7 questions
- LINLinde plc · 7 questions0%none of 7 questions
- PPGPPG Industries · 7 questions29%2 of 7 questions
- SHWThe Sherwin-Williams Company · 7 questions0%none of 7 questions
- ALBAlbemarle Corporation · 6 questions0%none of 6 questions
- ECLEcolab · 6 questions0%none of 6 questions
- LYBLyondellBasell · 6 questions0%none of 6 questions
- IFFInternational Flavors & Fragrances · 4 questions25%1 of 4 questions
Activity by reporting period
Questions recorded for each calendar quarter that companies’ reporting periods map to (not the call date), with the challenge rate for that period. Periods inside the range with no questions are shown as “No questions recorded”.
| Calendar period | Questions | Challenge rate | Companies |
|---|---|---|---|
| 2024 Q3 | 1 | 0%none of 1 question | 1 |
| 2024 Q4 | 9 | 0%none of 9 questions | 8 |
| 2025 Q1 | 9 | 0%none of 9 questions | 9 |
| 2025 Q2 | 9 | 11%1 of 9 questions | 9 |
| 2025 Q3 | 7 | 14%1 of 7 questions | 6 |
| 2025 Q4 | 11 | 9%1 of 11 questions | 10 |
| 2026 Q1 | 12 | 0%none of 12 questions | 9 |
| 2026 Q2 | 11 | 0%none of 11 questions | 10 |
- 2024 Q31 question · challenge rate 0% (none of 1 question) · 1 company
- 2024 Q49 questions · challenge rate 0% (none of 9 questions) · 8 companies
- 2025 Q19 questions · challenge rate 0% (none of 9 questions) · 9 companies
- 2025 Q29 questions · challenge rate 11% (1 of 9 questions) · 9 companies
- 2025 Q37 questions · challenge rate 14% (1 of 7 questions) · 6 companies
- 2025 Q411 questions · challenge rate 9% (1 of 11 questions) · 10 companies
- 2026 Q112 questions · challenge rate 0% (none of 12 questions) · 9 companies
- 2026 Q211 questions · challenge rate 0% (none of 11 questions) · 10 companies
Topics
Topics tagged on this analyst’s questions.
- Demand21
- Competitive Dynamics15
- Margin13
- Capital Allocation12
- Pricing12
- Revenue Growth10
- Supply Chain9
- Capex Investment7
- M&A6
- Innovation & R&D5
Show all 20 topics
- Geographic Expansion4
- Cost Pressure4
- Macroeconomic4
- Guidance Reliability3
- Regulation Policy2
- Product Launch2
- Fx2
- Inventory1
- Credit1
- Trade Tariffs1